Efficacy of Leucine rich alfa2 glycoprotein (LRG) as a biomarker in patients with diffuse lung disease
Not Applicable
- Conditions
- Diffuse lung disease
- Registration Number
- JPRN-UMIN000029019
- Lead Sponsor
- kochi Medical School, Kochi University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Not provided
Exclusion Criteria
Cases that can not cooperate with the examination conducted in this study Cases with other respiratory diseases such as lung cancer and non-tuberculous mycobacteria Cases in which consent has not been obtained for this research Case judged by the attending physician to be unqualified
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Whether LRG become the biomarker for disease differentiation and activity of disease
- Secondary Outcome Measures
Name Time Method Whether LRG become the biomarker for effect of treatment and prediction of prognosis